Details
Stereochemistry | ACHIRAL |
Molecular Formula | C9H9NO |
Molecular Weight | 147.1739 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O=C1CCC2=CC=CC=C2N1
InChI
InChIKey=TZOYXRMEFDYWDQ-UHFFFAOYSA-N
InChI=1S/C9H9NO/c11-9-6-5-7-3-1-2-4-8(7)10-9/h1-4H,5-6H2,(H,10,11)
Molecular Formula | C9H9NO |
Molecular Weight | 147.1739 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Synthesis of 3-methoxycarbonylmethyl derivatives of dihydroquinolone and dihydrochromenone. | 2001 Mar 23 |
|
Quinoline and derivatives at a tar oil contaminated site: hydroxylated products as indicator for natural attenuation? | 2007 Aug 1 |
|
In vivo active aldosterone synthase inhibitors with improved selectivity: lead optimization providing a series of pyridine substituted 3,4-dihydro-1H-quinolin-2-one derivatives. | 2008 Dec 25 |
|
Synthesis and biological activity of quinolinone and dihydroquinolinone p38 MAP kinase inhibitors. | 2008 Mar 15 |
|
Novel approach to 3,4-dihydro-2(1H)-quinolinone derivatives via cyclopropane ring expansion. | 2009 Mar 5 |
|
Ethyl 6-chloro-2-oxo-4-phenyl-1,2-dihydro-quinoline-3-carboxyl-ate. | 2009 Nov 4 |
|
Synthesis of highly enantioenriched 3,4-dihydroquinolin-2-ones by 6-exo-trig radical cyclizations of axially chiral alpha-halo-ortho-alkenyl anilides. | 2009 Oct 28 |
|
(RS)-3-Acetyl-2-methyl-4-(3-nitro-phen-yl)-1,4,5,6,7,8-hexa-hydro-quinolin-5-one. | 2009 Sep 26 |
|
Potent dihydroquinolinone dopamine D2 partial agonist/serotonin reuptake inhibitors for the treatment of schizophrenia. | 2010 May 1 |
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 04:29:10 GMT 2023
by
admin
on
Sat Dec 16 04:29:10 GMT 2023
|
Record UNII |
2CKG6TX32F
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
m6087
Created by
admin on Sat Dec 16 04:29:10 GMT 2023 , Edited by admin on Sat Dec 16 04:29:10 GMT 2023
|
PRIMARY | Merck Index | ||
|
DTXSID40203816
Created by
admin on Sat Dec 16 04:29:10 GMT 2023 , Edited by admin on Sat Dec 16 04:29:10 GMT 2023
|
PRIMARY | |||
|
2CKG6TX32F
Created by
admin on Sat Dec 16 04:29:10 GMT 2023 , Edited by admin on Sat Dec 16 04:29:10 GMT 2023
|
PRIMARY | |||
|
64796
Created by
admin on Sat Dec 16 04:29:10 GMT 2023 , Edited by admin on Sat Dec 16 04:29:10 GMT 2023
|
PRIMARY | |||
|
553-03-7
Created by
admin on Sat Dec 16 04:29:10 GMT 2023 , Edited by admin on Sat Dec 16 04:29:10 GMT 2023
|
PRIMARY | |||
|
49170
Created by
admin on Sat Dec 16 04:29:10 GMT 2023 , Edited by admin on Sat Dec 16 04:29:10 GMT 2023
|
PRIMARY |